13691-92-4

Basic information

• Product Name: Propanamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2,2-dimethyl-
• Synonyms: N-(4-chloro-3-(trifluoromethyl)phenyl)pivalamide;N-(4-chloro-3-(trifluoromethyl)phenyl)-2,2-dimethylpropanamide
• CAS NO: 13691-92-4
• Molecular Formula: C12H13ClF3NO
• Molecular Weight: 279.69
• Mol File: 13691-92-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Propanamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2,2-dimethyl-(13691-92-4)
• EPA Substance Registry System: Propanamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2,2-dimethyl-(13691-92-4)

Safety Data

• Hazardous Substances Data: 13691-92-4(Hazardous Substances Data)

Upstream product

• 3282-30-2 pivaloyl chloride 
• 320-51-4 4-chloro-3-trifluoromethyl-aniline 

Downstream Products

• 1371608-35-3 3-methyl-4-((R)-2-oxo-5-((S)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile 
• 1371608-36-4 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile 
• 1371608-77-3 (R)-4-(2-(hydroxymethyl)-5-oxopyrrolidin-1-yl)-3-methyl-2-(trifluoromethyl)benzonitrile 
• 1371608-76-2 (R)-3-methyl-4-(2-oxo-5-((trityloxy)methyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile 
• 1371608-78-4 C₁₄H₁₁F₃N₂O₂ 
• 573764-81-5 N-(4-Cyano-2-methyl-3-trifluoromethylphenyl)-2,2-dimethyl-propionamide 
• 573764-86-0 4-amino-3-methyl-2-trifluoromethylbenzonitrile 
• 112641-23-3 N-(4-Chloro-2-methyl-3-trifluoromethylphenyl)-2,2-dimethyl-propionamide 
• 875056-24-9 N-(4-chloro-2-methyl-5-trifluoromethylphenyl)-2,2-dimethylpropionamide 

Relevant articles and documents

SELECTIVE ANDROGEN RECEPTOR MODULATORS

This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.

BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION

The invention provides compounds according to formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia. Also provided are pharmaceutical compositions containing such compounds and processes for preparing some of the compounds of the invention.